Quarterly report pursuant to Section 13 or 15(d)

Note 4 - Revenue From Contracts With Customers - Schedule of Revenue by Products (Details)

v3.24.2.u1
Note 4 - Revenue From Contracts With Customers - Schedule of Revenue by Products (Details) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Net revenues $ 3,953,870 $ 3,341,185 $ 10,229,897 $ 12,434,946
FC2 Female Condom [Member]        
Net revenues 3,953,870 3,341,410 10,229,897 12,421,858
FC2 Female Condom [Member] | Sales Channel, U.S. Prescription Channel [Member]        
Net revenues 551,542 863,379 1,782,568 5,172,543
FC2 Female Condom [Member] | Global Public Healthcare Sector [Member]        
Net revenues 3,402,328 2,478,031 8,447,329 7,249,315
ENTADFI Capsules [Member]        
Net revenues $ 0 $ (225) $ 0 $ 13,088